Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal

Gene Jack Wang, Nora D. Volkow, Joanna S. Fowler, Jean Logan, Naji N. Abumrad, Robert Hitzemann, Naomi S. Pappas, Kathy Pascani

Research output: Contribution to journalArticle

192 Citations (Scopus)

Abstract

Dopamine may play a role in opiate withdrawal and dependence. We measured dopamine D2 receptor availability in 11 opiate-dependent subjects using PET and [11C]raclopride at baseline and during naloxone-precipitated withdrawal. Because [11C]raclopride is sensitive to endogenous dopamine, this strategy enabled us to test whether we could document in humans the DA reductions reported in animal models of opiate withdrawal. Results were compared with values from 11 controls, two of which also received naloxone. The ratio of the distribution volume in striatum to that in cerebellum (B(max)/K(d) + 1) was used as model parameter for D2 receptor availability. Baseline measures for B(max)/K(d) were lower in opiate-dependent subjects (2.44 ± 0.4) than in controls (2.97 ± 0.45, p ≤ .009). Naloxone precipitated an intense withdrawal in the abusers but did not change the B(max)/K(d) ratio. This study documents decreases in D2 receptors in opiate-dependent subjects but does not document significant changes in striatal DA concentration during acute withdrawal.

Original languageEnglish (US)
Pages (from-to)174-182
Number of pages9
JournalNeuropsychopharmacology
Volume16
Issue number2
DOIs
StatePublished - Feb 1997
Externally publishedYes

Fingerprint

Opiate Alkaloids
Dopamine D2 Receptors
Naloxone
Raclopride
Dopamine
Opioid-Related Disorders
Corpus Striatum
Opioid Receptors
Cerebellum
Animal Models

Keywords

  • naloxone
  • opiate abuse
  • PET, withdrawal

ASJC Scopus subject areas

  • Pharmacology

Cite this

Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. / Wang, Gene Jack; Volkow, Nora D.; Fowler, Joanna S.; Logan, Jean; Abumrad, Naji N.; Hitzemann, Robert; Pappas, Naomi S.; Pascani, Kathy.

In: Neuropsychopharmacology, Vol. 16, No. 2, 02.1997, p. 174-182.

Research output: Contribution to journalArticle

Wang, Gene Jack ; Volkow, Nora D. ; Fowler, Joanna S. ; Logan, Jean ; Abumrad, Naji N. ; Hitzemann, Robert ; Pappas, Naomi S. ; Pascani, Kathy. / Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. In: Neuropsychopharmacology. 1997 ; Vol. 16, No. 2. pp. 174-182.
@article{3313f97fa04c45268d9319f80dbbbd93,
title = "Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal",
abstract = "Dopamine may play a role in opiate withdrawal and dependence. We measured dopamine D2 receptor availability in 11 opiate-dependent subjects using PET and [11C]raclopride at baseline and during naloxone-precipitated withdrawal. Because [11C]raclopride is sensitive to endogenous dopamine, this strategy enabled us to test whether we could document in humans the DA reductions reported in animal models of opiate withdrawal. Results were compared with values from 11 controls, two of which also received naloxone. The ratio of the distribution volume in striatum to that in cerebellum (B(max)/K(d) + 1) was used as model parameter for D2 receptor availability. Baseline measures for B(max)/K(d) were lower in opiate-dependent subjects (2.44 ± 0.4) than in controls (2.97 ± 0.45, p ≤ .009). Naloxone precipitated an intense withdrawal in the abusers but did not change the B(max)/K(d) ratio. This study documents decreases in D2 receptors in opiate-dependent subjects but does not document significant changes in striatal DA concentration during acute withdrawal.",
keywords = "naloxone, opiate abuse, PET, withdrawal",
author = "Wang, {Gene Jack} and Volkow, {Nora D.} and Fowler, {Joanna S.} and Jean Logan and Abumrad, {Naji N.} and Robert Hitzemann and Pappas, {Naomi S.} and Kathy Pascani",
year = "1997",
month = "2",
doi = "10.1016/S0893-133X(96)00184-4",
language = "English (US)",
volume = "16",
pages = "174--182",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal

AU - Wang, Gene Jack

AU - Volkow, Nora D.

AU - Fowler, Joanna S.

AU - Logan, Jean

AU - Abumrad, Naji N.

AU - Hitzemann, Robert

AU - Pappas, Naomi S.

AU - Pascani, Kathy

PY - 1997/2

Y1 - 1997/2

N2 - Dopamine may play a role in opiate withdrawal and dependence. We measured dopamine D2 receptor availability in 11 opiate-dependent subjects using PET and [11C]raclopride at baseline and during naloxone-precipitated withdrawal. Because [11C]raclopride is sensitive to endogenous dopamine, this strategy enabled us to test whether we could document in humans the DA reductions reported in animal models of opiate withdrawal. Results were compared with values from 11 controls, two of which also received naloxone. The ratio of the distribution volume in striatum to that in cerebellum (B(max)/K(d) + 1) was used as model parameter for D2 receptor availability. Baseline measures for B(max)/K(d) were lower in opiate-dependent subjects (2.44 ± 0.4) than in controls (2.97 ± 0.45, p ≤ .009). Naloxone precipitated an intense withdrawal in the abusers but did not change the B(max)/K(d) ratio. This study documents decreases in D2 receptors in opiate-dependent subjects but does not document significant changes in striatal DA concentration during acute withdrawal.

AB - Dopamine may play a role in opiate withdrawal and dependence. We measured dopamine D2 receptor availability in 11 opiate-dependent subjects using PET and [11C]raclopride at baseline and during naloxone-precipitated withdrawal. Because [11C]raclopride is sensitive to endogenous dopamine, this strategy enabled us to test whether we could document in humans the DA reductions reported in animal models of opiate withdrawal. Results were compared with values from 11 controls, two of which also received naloxone. The ratio of the distribution volume in striatum to that in cerebellum (B(max)/K(d) + 1) was used as model parameter for D2 receptor availability. Baseline measures for B(max)/K(d) were lower in opiate-dependent subjects (2.44 ± 0.4) than in controls (2.97 ± 0.45, p ≤ .009). Naloxone precipitated an intense withdrawal in the abusers but did not change the B(max)/K(d) ratio. This study documents decreases in D2 receptors in opiate-dependent subjects but does not document significant changes in striatal DA concentration during acute withdrawal.

KW - naloxone

KW - opiate abuse

KW - PET, withdrawal

UR - http://www.scopus.com/inward/record.url?scp=0031060799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031060799&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(96)00184-4

DO - 10.1016/S0893-133X(96)00184-4

M3 - Article

C2 - 9015800

AN - SCOPUS:0031060799

VL - 16

SP - 174

EP - 182

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 2

ER -